Celerion has implemented VCT Verify from Verified Clinical Trials for participant identification and qualification for clinical research. The tool is designed to instantly identify ineligible candidates for enrollment, allowing for more effective screening and selection higher quality study participants. The system searches a global clinical database registry to identify participants that are currently enrolled in other clinical studies.

“Celerion continues to apply rigorous standards to protect the safety of participants and enhance data integrity while supporting our commitment to our clients. This implementation sets a standard in the industry to continue to improve clinical research and more effectively bring new drugs to the market,” said Phil Bach, vice president of Global Clinical Research at Celerion. “We are excited to partner with Verified Clinical Trials, the leader in this specialized field, to take a firm stance on ensuring the highest quality data and participants for our clients.”

“Verified Clinical Trials offers a comprehensive and unique clinical research database registry to enhance the quality of both early and late stage studies globally. The system has been designed to streamline the clinical trial process and offers protection from various other potential liabilities,” said Mitchell Efros, M.D. FACS, chief executive officer at Verified Clinical Trials. “We are pleased to be working with Celerion, the first CRO to implement this product, as they continue to demonstrate their leadership position in the industry.”